Navigation Links
Data Demonstrate that Obagi Medical Products' Condition & Enhance Skin Care System is an Effective Complement to Facial Rejuvenation Procedures
Date:2/1/2008

Study of more than 2,500 patients shows marked improvement of skin texture,

color and overall appearance

SAN ANTONIO, Feb. 1 /PRNewswire-FirstCall/ -- Obagi Medical Products, Inc. (Nasdaq: OMPI), a leader in topical aesthetic and therapeutic skin health systems, announced the results of a wide-ranging investigator assessment study on the effects of its Condition & Enhance System on facial rejuvenation procedures today at the 66th Annual Meeting of the American Academy of Dermatology in San Antonio. The data show that the unique 4% hydroquinone- based system in combination with common non-surgical and surgical facial rejuvenation procedures improved overall skin quality in up to 80 percent of subjects.

As rated by investigators, eighty-three percent of patients treated with the Condition & Enhance System and botulinum toxin type A injections (i.e., Botox(R)) experienced a 1-grade improvement (from moderate to mild or mild to none) in hyperpigmentation. Additionally, 33 percent of subjects achieved a 2-grade improvement (from severe to mild or moderate to none) in this type of sun damage related discoloration. Similar levels of improvement were also seen in tactile roughness and sallowness. These results are independent of the effects of botulinum toxin type A, therefore supporting the benefit of using the unique Condition & Enhance System in order to provide a more balanced overall aesthetic result.

The 4% hydroquinone-based skin care program, known commercially as the Obagi(R) Condition & Enhance System, helps correct premature photoaged skin and prevent future skin damage. The system is comprised of products that work together to improve overall skin health and appearance. The Condition & Enhanc
'/>"/>

SOURCE Obagi Medical Products, Inc.
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
4. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
5. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
6. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
7. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
8. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
9. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
10. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
11. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... N.J., Nov. 30 MedQuist ...ology-enabled clinical documentation services, tod...Nuance Communications, Inc. (Nuance) under which M...ch recognition engine and processing software for ... front-end speech recognition application for all ...
(Date:11/30/2009)...YORK, Nov. 30 Reportlinker.com ann...ble in its catalogue: ,, Diabetes Diagnostics ...eportlinker.com/p0164347/Diabetes-Diagnostics---A-...agnosis market is driven by a steady increase in t...in the developed and developing parts of the world...
(Date:11/30/2009).... 30 Dr. Jocelyn Rapelyea, Associa...George Washington University Medical Center in Was...ntified with Breast-Specific Gamma Imaging (BSGI) ...for needle biopsy as well, as for pre-operative lo...ological Society of North America (RSNA). ,, BS...
Breaking Medicine Technology:MedQuist Signs Agreement Extending Use of Real-Time Speech Recognition Engine to Wide Range of Medical Specialties 2Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 2Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 3Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 4Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 5Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 6Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 7Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 8Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 9Breast-Specific Gamma Imaging Identifies Occult Lesions Using Multi-Modality Imaging for Biopsy 2Disability Rates Continue Steady Climb According to CDAs 2008 Disability Claims Review 56752 1Disability Rates Continue Steady Climb According to CDAs 2008 Disability Claims Review 56752 2Disability Rates Continue Steady Climb According to CDAs 2008 Disability Claims Review 56752 3Prime Retail Launches Operation Shop Pink 56749 1Prime Retail Launches Operation Shop Pink 56749 2Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 1Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 2Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 3Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 4
...Reported Safety & Tolerability Profile,in Subj... CHICAGO, June 25, 2007 /PRNewswire-FirstCall/ -- ...eeting of the American Diabetes,Association demons...l-peptidase-4 (DPP-4) in development by Bristol-My...n with metformin,exhibited a statistically signif...
...NYVALE, Calif., June 27, 2007,/PRNewswire-FirstCal...ary results from two open-label, multi-center Phas...f Xcytrin(R),(motexafin gadolinium) Injection, the...with Alimta(R) (pemetrexed) and in,combination wit...nt,for patients with non-small cell lung cancer (N...
Other Medicine Technology:Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 2Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 3Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 4Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 5
(Date:11/30/2009)...RNewswire/ -- HealthPlus of Michigan today announc... plans designed for Medicare-eligible people looki...ccess to quality health care. ,, HealthPlus Me... in Michigan, according to the "America,s Best Hea... & World Report and the National Committee on ...
(Date:11/30/2009)...or Alonzo L. Fulgham ,, WASHINGTON, Nov. 30 /P...al community once again recognizes World AIDS Day ...ldwide. This is also a time to renew our commitme... and pay homage to the millions of people who have...er in the U.S. President,s Emergency Plan for AIDS...
(Date:11/30/2009)...ewswire/ -- Major League Baseball,s Mark Teahen,... and recently acquired by the Chicago White Sox, w...d is given annually to a Major League Baseball pla...dication of baseball great Fred Hutchinson, both o...ands, Calif., native made his MLB debut with the R...
(Date:11/30/2009)...ent for blood-borne diseases, researchers say , ... medical students get stuck by needles, putting th...n fail to alert hospital authorities, which increa.... , The researchers interviewed 699 surgery res... 59 percent -- had experienced needlestick injurie...
(Date:11/30/2009)...RNewswire-USNewswire/ -- SEIU Local 21LA members a... Sodexo will hold a rally Tuesday, Dec. 1, 2009, a...arters, 3800 Desire Parkway, New Orleans, to prote...iplinary policies that target employees who are il...dexo employees who clean schools in the Recovery S...
Breaking Medicine News(10 mins):Health News:HealthPlus Launches New Medicare Advantage Plans 2Health News:HealthPlus Launches New Medicare Advantage Plans 3Health News:USAID Recognizes World AIDS Day 2Health News:Mark Teahen Named 2009 Hutch Award Winner 2Health News:Med Students Often Fail to Report Needlestick Injuries 2Health News:As H1NI Hits New Orleans in Force: School Custodians to Hold Rally to Call on Contractor to Stop Penalizing Workers Coping With Illness 2
...hat doing household activities like cleaning the h...prevent hypertension and conditions of prehyperten...rdless of intensity, four hours of accumulated dai... from prehypertensive to normal -- for an average ...
...Electric (GE), Tuesday launched HF Advantage, the ...nd made in India for the domestic and internationa...technology, the state-of-the-art product is equipp...rs at the John F. Welch Technology Centre of GE in...
...a new cheaper tissue culture vaccine for Japanese ...reported 200 deaths and 700 patients with infectio...y year due to the endemic infection of Encephaliti...4 hours, in which 12 persons died. The health ...
... of Wisconsin-Madison had reported that specific b...re affected by stress, like asthma. The study...oceedings of the National Academy of Sciences, // ...ggest potential future targets for the development...
...i may soon become part of the Indian government's ...to spread awareness about HIV/AIDS and promote the...rts have failed in reaching supplies of condoms, t... country. It has been proposed to advertise...
...ovarian cancer, according to a new Danish study, w...sk of some other forms of cancer. Women who ex...uction in the risk of development of ovarian cance...ercise habits of nearly 28,000 men and women, has ...
Other Medicine News:Health News:New X-ray machine launched by GE Healthcare 2
...x® Thermovent® T helps provide protection ... It is small and extremely lightweight making it i...With a high rate of heat and moisture recovery, it...ention., ,All HMEs and filters have ISO standard ...
circuitGuard™
Clear-Guard II™ with Port and Flextube
Clear-Guard II™
Medicine Products: